跳至主要内容
临床试验/CTRI/2025/09/094869
CTRI/2025/09/094869尚未招募不适用

Comparison of Two Different Doses of Sugammadex for Reversal of Rocuronium Induced Neuromuscular Blockade

Dr Annie Paul1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
66
试验地点
1
主要终点
Time from administration of Sugammadex to achieving TOFR greater than 0.9

研究概览

简要总结

This study compares the efficacy of two doses of Sugammadex, 1mg per kg and 2mg per kg, a drug used to reverse Rocuronium induced neuromuscular blockade in surgical patients. Outcomes include time to full reversal, percentage achieving target within 5min.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • ASA physical status 1 or 2 Surgeries under general anaesthesia with controlled ventilation for equal or greater than 40 minutes duration.

排除标准

  • Known hypersensitivity to study drugs Neuromuscular disorders Medications altering effects of NMBA.

结局指标

主要结局

Time from administration of Sugammadex to achieving TOFR greater than 0.9

时间窗: 18 months

次要结局

未报告次要终点

研究者

发起方
Dr Annie Paul
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Annie Paul

Vardhman Mahavir Medical College and Safdarjung Hospital

研究点 (1)

Loading locations...

相似试验

Comparing Two Doses of Sugammadex for Reversal of... | 临床试验